Investment
Features
FeesSafety
Academy
More
Pluang+

Contango completes phase one of Lucky Shot drilling, acquires lease and royalty rights in Alaska

Company Fundamentals
05 May 2026
PRNewsWire
View Source
Bullish
pluang ai news

Contango Silver and Gold Inc. has finished the initial phase of its 2025/2026 underground diamond drilling program at the Lucky Shot Project in Alaska. This phase is part of a larger 18,000-meter exploration campaign aimed at expanding resources, improving geological understanding, and supporting a resource update and feasibility study planned for the first half of 2027. Additionally, Contango acquired the underlying lease and net smelter returns royalty for Lucky Shot, enhancing the project's economic potential. These developments position the company to advance its technical studies and potentially increase the project's value.

More News

Global pharmaceutical surfactants market to reach $6.93B by 2035 with 4.42% CAGR, driven by drug formulation demand.

Global pharmaceutical surfactants market to reach $6.93B by 2035 with 4.42% CAGR, driven by drug formulation demand.

The global pharmaceutical surfactants market, valued at $4.5 billion in 2025, is projected to grow to $6.93 billion by 2035 at a CAGR of 4.42%. Growth is fueled by increasing use in drug formulation to enhance solubility, stability, and bioavailabili...

Market News
Bullish
33 minutes ago
Proposed $20M sale of The Dolphin Company risks 90% monopoly, violates Mexican Supreme Court ruling.

Proposed $20M sale of The Dolphin Company risks 90% monopoly, violates Mexican Supreme Court ruling.

The Dolphin Company's current management proposed selling its main assets in Mexico to Delphinus Blue Planet, a Grupo Xcaret subsidiary, for $20 million. This deal would give Delphinus control over more than 90% of dolphin habitats in Mexico, creatin...

Market News
Bearish
3 hours ago
MaxLinear rated Strong Buy with $111 target despite post-earnings drop, citing growth in AI connectivity.

MaxLinear rated Strong Buy with $111 target despite post-earnings drop, citing growth in AI connectivity.

MaxLinear's stock fell after earnings, but the analyst maintains a Strong Buy rating with a revised price target of $111 per share, down from $196.50. The drop is attributed to valuation compression and broader semiconductor industry trends rather th...

Analyst Insights
Bullish
4 hours ago
Johnson & Johnson agrees to $5.5B settlement over talc products linked to cancer claims.

Johnson & Johnson agrees to $5.5B settlement over talc products linked to cancer claims.

Johnson & Johnson has reached a historic $5.5 billion settlement to resolve claims from about 70,000 women and families alleging its talc products, including Johnson's Baby Powder, contained asbestos and caused cancers such as ovarian cancer and meso...

Market News
Bearish
4 hours ago
Bitcoin drops 2.7% as South Korea's Kospi plunges 10%, U.S. Senate delays crypto regulation vote.

Bitcoin drops 2.7% as South Korea's Kospi plunges 10%, U.S. Senate delays crypto regulation vote.

Bitcoin fell about 2.7% to around $63,200 following the U.S. market close, dragged down by a sharp 10% drop in South Korea's Kospi index, which hit its lowest since April. The U.S. Senate postponed a vote on the CLARITY Act, delaying crypto regulator...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App